Tech Company Financing Transactions

Carmot Therapeutics Funding Round

Carmot Therapeutics closed a $160 million Series D funding round on 7/26/2022. Investors included The Column Group, Deep Track Capital and Horizons Ventures.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
The company intends to use the funds for the completion of phase 2 studies for CT-388, a once weekly, dual modulator of the GLP-1 and GIP incretin receptors, phase 1 studies for CT-996, an oral small molecule GLP-1 receptor agonist, and phase 2 studies for CT-868, a first-in-class fully biased GLP-1/GIP modulator in addition to the advancement of several pre-clinical programs.

Company Information

Company Status
Private & Independent
Mailing Address
740 Heinz Ave.
Berkeley, CA 94710
Email Address
Carmot Therapeutics develops drugs to treat inflammatory, metabolic and neurological diseases.
Carmot Therapeutics LinkedIn Company Profile
Social Media
Carmot Therapeutics Company Twitter Account
Company News
Carmot Therapeutics News
Carmot Therapeutics on Facebook
Carmot Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Stig Hansen
  Stig Hansen LinkedIn Profile  Stig Hansen Twitter Account  Stig Hansen News  Stig Hansen on Facebook
Chief Medical Officer
Allan Gordon
  Allan Gordon LinkedIn Profile  Allan Gordon Twitter Account  Allan Gordon News  Allan Gordon on Facebook
VP - Bus. Development
James Watson
  James Watson LinkedIn Profile  James Watson Twitter Account  James Watson News  James Watson on Facebook



Browse more venture capital transactions:

Prev: 7/26/2022: Butlr venture capital transaction
Next: 7/26/2022: Underdog venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary